Dimensional Fund Advisors’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$65.7M Buy
2,551,861
+145,144
+6% +$3.36M 0.01% 1443
2026
Q1
$49.5M Buy
2,406,717
+142,679
+6% +$3.22M 0.01% 1502
2025
Q4
$53.7M Buy
2,264,038
+128,415
+6% +$3.13M 0.01% 1468
2025
Q3
$53.2M Buy
2,135,623
+203,149
+11% +$4.37M 0.01% 1489
2025
Q2
$44.4M Buy
1,932,474
+260,731
+16% +$6.04M 0.01% 1567
2025
Q1
$37.5M Buy
1,671,743
+255,508
+18% +$5.94M 0.01% 1616
2024
Q4
$27.7M Buy
1,416,235
+138,747
+11% +$2.75M 0.01% 1851
2024
Q3
$23.3M Buy
1,277,488
+158,869
+14% +$3.03M 0.01% 1938
2024
Q2
$19.4M Buy
1,118,619
+173,934
+18% +$3.08M 0.01% 1966
2024
Q1
$18.5M Buy
944,685
+320,234
+51% +$6.76M 0.01% 2027
2023
Q4
$14.4M Buy
624,451
+28,271
+5% +$633K ﹤0.01% 2144
2023
Q3
$13.7M Buy
596,180
+9,682
+2% +$246K ﹤0.01% 2100
2023
Q2
$15.3M Buy
586,498
+303,852
+108% +$8.03M ﹤0.01% 2057
2023
Q1
$7.8M Buy
+282,646
New +$7.46M ﹤0.01% 2325

Other funds holding PRVA

Dimensional Fund Advisors's PRVA Position: Q2 2026 in Review

Dimensional Fund Advisors increased its Privia Health (PRVA) stake by 6% in Q2 2026, buying an estimated $3.36M and bringing the position to 2,551,861 shares worth $65.7M. The position accounts for 0.01% of the portfolio, ranked #1443.

Dimensional Fund Advisors first reported a position in PRVA in Q1 2023 and has held it in 14 quarters since. 301 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • Dimensional Fund Advisors held 2,551,861 shares of Privia Health worth $65.7M as of Q2 2026.
  • Dimensional Fund Advisors bought 145,144 Privia Health shares in Q2 2026, an estimated $3.36M.
  • Privia Health made up 0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #1443 holding.
  • Dimensional Fund Advisors first reported a position in Privia Health in Q1 2023 and has held it in 14 quarters since.
  • 301 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.